What this post covers:
- The main contract types used in specialty VBC and how each one works
- A readiness checklist to run before any payer conversation
- Negotiation considerations specific to specialty medicine
- The six contract terms that most often hurt specialty providers
- How to evaluate a VBC enabler or partner
What Is a Value-Based Care Contract?
A value-based care contract is a written agreement between a provider and a payer — Medicare, Medicare Advantage, Medicaid, or a commercial health plan — that ties reimbursement to clinical outcomes and total cost of care rather than the volume of services delivered. Instead of being paid per procedure or per visit, providers are paid based on whether their patients achieve defined health outcomes and whether the total cost of caring for those patients stays within an agreed benchmark.
How Specialty Care VBC Contracts Differ From Primary Care
Most VBC commentary is written with primary care in mind. That makes sense historically — primary care was the first major entry point for value-based payment models, and programs like the Medicare Shared Savings Program were designed around population health management. But specialty care operates differently, and contracts that work well for primary care practices often don’t translate cleanly.
Four differences matter most:
- Episode-based rather than population-based. Specialty VBC contracts are often structured around a defined treatment episode — a cataract surgery, an oncology treatment cycle, a rheumatoid arthritis management period — rather than total cost of care across a broad patient population.
- Condition-specific quality metrics. Generic HEDIS measures don’t capture what specialty care actually delivers. Retina outcomes, chemotherapy response rates, and biologic stewardship require subspecialty metrics, not general wellness indicators.
- Attribution complexity. Determining which provider “owns” a patient for cost accountability is much harder in specialty care. A patient with multiple chronic conditions may see three or four specialists, a PCP, and a hospitalist in a single year.
- Smaller patient panels. Specialty practices see fewer patients per condition than primary care sees across all conditions. That creates statistical credibility problems — one complex case can significantly move your performance numbers.
The Regulatory Context
CMS has committed to moving 100% of Traditional Medicare beneficiaries into value-based care programs by 2030. Medicare Advantage plans are moving faster than Traditional Medicare, and they are increasingly writing specialty-focused VBC contracts directly with specialty practices. On the federal side, the Center for Medicare and Medicaid Innovation (CMMI) has launched specialty-focused models including the Oncology Care Model and its successor, the Enhancing Oncology Model. These programs define episode structures, quality metrics, and payment methodologies that are beginning to serve as templates for how specialty VBC contracts are written more broadly.
Types of Value-Based Contracts for Specialty Practices
There is no single value-based contract model. Specialty providers will encounter several structures, each with a different risk/reward profile. Understanding the differences before negotiation is essential — the name on the contract doesn’t tell you much about what you’re actually agreeing to.
Bundled Payment Models
A bundled payment is a single, fixed payment covering all services within a defined episode of care. If the actual cost of delivering the episode comes in below the bundle target, the provider keeps the savings. If it runs over, the provider owes the difference back — either immediately or through adjustments to future payments.
Bundled payments are most relevant for surgical specialties and episodic procedural care — joint replacement, cardiovascular procedures, and cataract surgery are classic examples. They work best when the scope of care is well-defined and the clinical pathway is relatively predictable.
The risk structure is straightforward but unforgiving. Complications, readmissions, and unplanned post-acute care can all flow into the bundle and erode margin quickly. This is why the boundaries of the episode — what is included, what is excluded, and when the episode ends — matter more than almost any other contract term.
Shared Savings Programs — One-Sided
In a one-sided shared savings model, the practice shares in any savings generated when total costs for the attributed patient population come in below an agreed benchmark. If costs exceed the benchmark, there is no financial penalty. The provider is playing with upside only.
This structure is well suited to practices new to value-based care, or practices with smaller panel sizes where statistical noise can produce unpredictable results from year to year. It is also the model that most ACO participation arrangements start with.
Shared Savings Programs — Two-Sided
Two-sided shared savings adds downside risk. The practice still shares in savings when costs come in under benchmark but now absorbs a portion of the overages when costs exceed it. In exchange, the upside percentage is usually higher than it is under a one-sided arrangement.
They are not a starting point. Practices moving from one-sided to two-sided should have at least two full performance years of data showing they can consistently deliver savings before taking on downside risk.
Pay-for-Performance Contracts
Pay-for-performance contracts tie bonus payments to hitting defined quality thresholds. These are not shared savings arrangements — the underlying reimbursement is usually still fee-for-service, with a quality-based adjustment layered on top.
The quality thresholds vary significantly by specialty:
- Ophthalmology: visual acuity outcomes, anti-VEGF treatment adherence, diabetic retinopathy screening rates
- Oncology: care plan adherence, emergency department avoidance, patient-reported outcomes, treatment-on-pathway compliance
- Rheumatology: disease activity scores, biologic stewardship, functional status improvement
Pay-for-performance is often the lowest-risk way into value-based contracting because the base reimbursement doesn’t change — only the bonus. The trade-off is that the upside is limited compared to shared savings models.
Before You Sign: Readiness Assessment
Most practices enter VBC contract negotiations without a clear picture of their own data capabilities. Payers know this and set terms accordingly. The checklist below covers what you need to evaluate before any contract conversation.
Operational Readiness Checklist
- Patient volume. Do you see enough patients in the target condition to achieve statistical credibility? Panel sizes under 500 attributed patients per condition create significant noise in performance metrics.
- Data infrastructure. Can you pull clinical outcome data, cost data, and utilization data in a format the payer will accept? If you can’t measure your own outcomes today, you can’t negotiate a fair contract.
- Care coordination. Do you have formal referral relationships and shared protocols with referring PCPs and other specialists? VBC performance is rarely about what happens inside your practice alone.
- Coding and documentation. Is your clinical documentation thorough enough to support risk adjustment claims? Under-documented complexity shows up as artificially expensive patients.
- Financial reserves. Two-sided risk models require a buffer. Do you have the liquidity to absorb a bad performance year without cutting operations?
- Technology. Do you have or have access to a platform for tracking quality metrics and benchmarking performance in real time? Waiting for annual payer reports to find out how you’re doing is too late.
Identifying the Right Contract Type for Your Practice
A simple decision framework: patient volume + risk tolerance + data maturity = starting point for contract model selection.
The most common mistake is taking on more contractual risk than the practice’s data and coordination capabilities can support.
What to Watch Out For: Contract Terms That Hurt Specialty Providers
This is the section most VBC guides skip. Specialty providers lose money in VBC contracts not because VBC is a bad model, but because of the way the contracts can be written.
Here are the six contract terms that most commonly create problems for specialty practices.
| Red Flag | Why It Matters | What to Do |
|---|---|---|
| Vague episode definitions | You end up owning costs outside your control | Demand explicit start/end dates and excluded services in writing |
| No risk adjustment for complex patients | Your sicker panel tanks your scores unfairly | Negotiate specialty-specific severity indexing |
| Attribution based on a single visit | Patients get assigned to you for total cost of care based on one appointment | Push for plurality-based or condition-specific attribution |
| Benchmarks set against primary care norms | Specialty utilization patterns are inherently different | Request specialty-specific benchmarks, not system-wide averages |
| Short measurement periods (<12 months) | Statistical noise punishes small practices | Negotiate 18–24 month periods or rolling averages |
| Audit rights not defined | Disputed settlements with no recourse | Require clear audit process and dispute resolution terms |
1. Poorly Defined Episode Boundaries
Who owns post-acute costs? Readmissions? Complications from comorbidities the specialist did not treat? If the contract does not answer these questions explicitly, the specialist is often left holding costs they could not have influenced.
What to negotiate: explicit start and end dates for episodes, a defined list of included and excluded services, and a clear attribution model for complications.
2. Risk Adjustment That Ignores Specialty Patient Complexity
Specialty practices disproportionately see complex, high-acuity patients. If the contract uses a generic risk adjustment model built for primary care populations, your panel will look more expensive than it actually is relative to appropriate comparators.
What to negotiate: specialty-specific severity indexing, explicit carve-outs for high-complexity cases, and a review process for outlier cases.
3. Attribution Models That Don’t Reflect Clinical Reality
Some contracts attribute a patient to a specialist based on a single visit — then hold that specialist accountable for the patient’s total cost of care. This is a significant risk in specialty medicine where patients cycle between multiple providers.
What to negotiate: plurality-based attribution (the provider with the most visits) or condition-specific attribution tied to the specialty’s scope.
4. Benchmarks Set Against the Wrong Comparator Group
If your shared savings benchmark is calculated against a health system’s average that includes high-volume primary care, your specialty utilization patterns will look like outliers even when they are clinically appropriate.
What to negotiate: specialty-specific benchmarks, peer group comparisons, and transparency into how the benchmark was calculated.
5. Measurement Periods Too Short for Small Panels
Statistical credibility is a real problem in specialty care. With a panel of 200 attributed patients instead of 2,000, one bad outcome or one catastrophic case can move your performance metrics significantly. Short measurement windows amplify this noise.
What to negotiate: 18–24 month measurement periods, rolling averages, or minimum panel size thresholds before penalties apply.
6. No Clear Audit or Dispute Resolution Process
Payment disputes in VBC contracts are common. If the contract does not define how data discrepancies are handled, who adjudicates disputes, and what the timeline is for resolution, you have no recourse when settlements don’t look right.
What to negotiate: explicit audit rights, agreed-upon data sources, and a defined escalation process.
How to Evaluate a Value-Based Care Enabler or Partner
Most specialty practices don’t have the internal infrastructure to manage VBC contracts alone. The data analytics, care coordination, and payer negotiation expertise required is substantial, and building all of it in-house is a multi-year commitment. This is where VBC enablers — also called Management Services Organizations, or specialty VBC companies — come in.
A VBC enabler typically provides the analytics platform, care coordination support, and contract negotiation expertise that a specialty practice needs to succeed under value-based arrangements. The quality of these partners varies significantly, and choosing the wrong one can be worse than no partner at all.
Questions to ask when evaluating a potential partner:
- Do they have specialty-specific experience — not just primary care VBC? The expertise is not transferable.
- What data platform do they provide, and does it give you real-time performance visibility?
- Do they support contract negotiation, or do they only come in after you’ve signed? Good partners are involved before the terms are set.
- What is their track record in your specific specialty? Ask for references from practices in your field.
- How do they handle the statistical credibility problem for small panel sizes? If they don’t have a clear answer, they haven’t done this before.
- What is the financial structure, and do their incentives align with yours? A partner paid based on your success is different from one paid based on your participation.
Conclusion: Enter the Contract Knowing the Terrain
Value-based care contracts offer real upside for specialty providers — better alignment between clinical effort and financial reward, more stable revenue, and the ability to demonstrate outcomes that justify premium reimbursement. But the contracts themselves are complex, and the terms matter.
The practices that do well in VBC are not necessarily the ones with the best clinical outcomes. They are the ones who understood what they were signing before they signed it.
Immediate Next Steps
- Run the readiness checklist before any payer conversation.
- Identify your highest-volume conditions and check whether they have defined episode structures in existing CMMI or Medicare Advantage programs.
- Get your data house in order. You can’t negotiate a fair contract if you can’t measure your own outcomes.
- Evaluate whether you need a VBC enabler or MSO partner with specialty-specific experience.
About OMI
OMI works with specialty practices in ophthalmology, oncology, and rheumatology to build and manage value-based care programs that work at the specialty level. The OMI PULSE platform gives practices real-time performance visibility, and the OMI team supports contract negotiation, care coordination, and performance management end-to-end.
If you’re evaluating a value-based care contract, the readiness checklist above is a good place to start. If you’d like to see how OMI’s approach maps to your practice, here are the relevant resources: